| Field | Specification |
|---|---|
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
SignaGen's innovative, proprietary lipid conjugation technology underlies LipoD293™ (Ver. II), whose design and proprietary enhancers aim at highly efficient DNA transfection in HEK293 cells along with other mammalian cell types. From this second-generation liposome-based DNA transfection reagent SignaGen reports exceptionally high transfection efficiency in HEK293-derived cells and in many other mammalian cells, cytotoxicity staying low throughout.
Refined chemistry separates it from the previous formulation and brings a 3–4 fold improvement in gene delivery efficiency. Approximately 666 transfections in 24-well plates, or 333 in 6-well plates, can be run from one 1.0 mL vial of LipoD293™ (Ver. II) Reagent.

Specifications
| Transfection Type | DNA Transfection |
|---|---|
| Application Setting | In Vitro |
| Pre-Optimized | No — General-Purpose Formulation |
| Storage | Store at 4 °C. When stored under recommended conditions, the product is stable for 12 months or longer. |
Features
- Preferred option for cells that are hard to transfect
- Supports exceptionally high viral titers
- Highly effective with very large DNA constructs (up to 180 kb)
- Works equally well in suspension HEK293 cells (e.g., 293F, 293H)
- Enables high-level recombinant protein expression
- Higher transfection efficiency when serum and antibiotics are present in 293 cells
- Exceptional results with both single-DNA transfection and multi-DNA co-transfection
- Highly cost-effective transfection option
Performance Data










Applications
This DNA transfection reagent supports a range of molecular biology applications including transient and stable transfection, reporter assays, protein expression studies, and gene function analysis in mammalian cell systems.
Safety & Handling
- General Protocol for Transfecting Mammalian Cells (PDF)
- Short Protocol – DNA Transfection (PDF)
- Protocol for Lentivirus Packaging in HEK293T Cells (PDF)
- Protocol for AAV Packaging in HEK293T Cells (PDF)
- Protocol for Adenovirus Packaging in HEK293A Cells (PDF)
- General Protocol for Transfecting HEK293 and CHO Cells in Suspension (PDF)
- Technical Note & Transfection Tips (PDF)
Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Yang L, Renauer P, Tang K, et al.. OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours. Nature (2026). 10.1038/s41586-026-10149-8
Cheung J, Hunt B, Wahed S, et al.. Distinct T cell functions enable efficient immunoediting and prevent tumor emergence of developing sarcomas. Cancer Cell (2025) 43(12), 2311-2326.e4.. 10.1016/j.ccell.2025.09.005
Sun Y, Wang X, Zhang D, et al.. Brain-wide neuronal circuit connectome of human glioblastoma. Nature (2025) 641(8061), 222-231.. 10.1038/s41586-025-08634-7
Despic V, Jaffrey S. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature (2023) 614(7947), 358-366.. 10.1038/s41586-022-05668-z